Slim Expert softgel capsules Dietary Supplement. One month supply/ 30 softgels. 1 softgel - 650 mg.
Published April 23, 2014 · Recall initiated: October 7, 2013
Summary
FDA records drug Class I recall D-1233-2014, published April 23, 2014 and initiated October 7, 2013. Recalling firm: B @ B Trade Inc.; Status: Terminated; Reported quantity: 10 bottles; Lot: ALL LOTS. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- B @ B Trade Inc.
- Distributor
- Nationwide
- Lot
- ALL LOTS
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASlim Fortune capsules Dietary Supplement. Each bottle contains 30 capsules.April 23, 2014
- FDALidiy capsules Dietary Supplement. Each bottle contains 30 capsules.April 23, 2014
- FDA1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.April 23, 2014
- FDAProlifta Dietary Supplement Prolifta, 400mg/capsule, Packaged in 1 and 2 capsule blister packs and 4, 12, andApril 23, 2014
- FDAPHUK Sexual Enhancement Ultimate Pleasure, 400mg/capsule, packaged in 1 and 2 capsule blister packs andApril 23, 2014
- FDAReusable latex breathing bags with multiple part numbers and sold as part of test lung part number andApril 16, 2014
Questions about this recall
Was Slim Expert softgel capsules Dietary Supplement. One month supply/ 30 softgels. 1 softgel - 650 mg. recalled?
Yes. FDA published recall D-1233-2014 on April 23, 2014. Reported hazard: Marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit